Jeremy R. Graff - 22 Jan 2026 Form 4 Insider Report for Allarity Therapeutics, Inc. (ALLR)

Reporting relationship: President and Chief Development Officer
Issuer ticker: ALLR
Reported as of: 22 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Oct 2026, 17:12:52 UTC
Prior SEC filing: 16 Jan 2026
Next SEC filing: 30 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeremy R. Graff

Key filing fact

Jeremy R. Graff filed Form 4 for Allarity Therapeutics, Inc. (ALLR) on 09 Oct 2026.

Key facts

This page summarizes Jeremy R. Graff's Form 4 filing for Allarity Therapeutics, Inc. (ALLR).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 09 Oct 2026, 17:12.

Change

Previous filing in this sequence was filed on 16 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001975028 Primary reporting owner

Graff Jeremy R.

Relationship: President and Chief Development Officer
Address: C/O ALLARITY THERAPEUTICS, INC., 123 E TARPON AVE, TARPON SPRINGS
Signature: /s/ Jeremy R. Graff
Signature date: 09 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALLR transaction

Common Stock

Options Exercise

Transaction value
Shares: +48,147
Change %: +194%
Price
Shares after: 73,028
Date: 22 Jan 2026
Ownership: Direct
Footnotes: F1

ALLR transaction

Common Stock

Tax liability

Transaction value
Shares: -17,814
Change %: -24%
Price: $1.18^*
Shares after: 55,214
Date: 22 Jan 2026
Ownership: Direct
Footnotes: F3

ALLR transaction

Common Stock

Options Exercise

Transaction value
Shares: +39,494
Change %: +72%
Price
Shares after: 94,708
Date: 30 Sep 2026
Ownership: Direct
Footnotes: F1

ALLR transaction

Common Stock

Tax liability

Transaction value
Shares: -14,613
Change %: -15%
Price: $0.9700^*
Shares after: 80,095
Date: 30 Sep 2026
Ownership: Direct
Footnotes: F3, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALLR transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -48,147
Change %: -22%
Price: $0.000000^*
Shares after: 175,283
Date: 22 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 48,147
Exercise price
Footnotes: F1, F2

ALLR transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -39,494
Change %: -13%
Price: $0.000000^*
Shares after: 269,122
Date: 30 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 39,494
Exercise price
Footnotes: F1, F2, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date.

Footnote F3

Represents shares withheld by the Issuer to satisfy tax withholding obligations arising upon the vesting and settlement of restricted stock units. The shares were withheld based on the fair market value of the Issuer's common stock on the applicable vesting date.

Footnote F4

The amount reported in column 9 reflects 175,283 restricted stock units outstanding following the January 22, 2026 settlement, plus 133,333 restricted stock units granted on January 28, 2026 and previously reported, less 39,494 restricted stock units settled on September 30, 2026.

Footnote F5

The 381,644 amount previously reported in column 5 of Table I of the Reporting Person's Form 4/A filed April 30, 2026 combined issued shares of common stock and unvested restricted stock units and did not reflect the 17,814 shares withheld on January 22, 2026. This Form 4 reports issued shares of common stock in Table I and unvested restricted stock units separately in Table II. After giving effect to the January 22, 2026 vesting and withholding and the January 28, 2026 restricted stock unit grant, the correct balances were 55,214 shares of common stock and 308,616 restricted stock units.

SEC remarks

President and Chief Development Officer